ripekg:evaluation/RIPEAE6C99CEB4A528D11 |
prov:used |
ripekg:study-design-evidence/RIPEAE6C99CEB4A528D11 |
ripekg:study-design-evidence/RIPEAE6C99CEB4A528D11 |
rdf:type |
rdfs:Resource |
ripekg:study-design-evidence/RIPEAE6C99CEB4A528D11 |
rdf:type |
owl:Thing |
ripekg:study-design-evidence/RIPEAE6C99CEB4A528D11 |
rdf:type |
ripe:IntegrityAssessmentEvidenceIntegrity assessment evidence |
ripekg:study-design-evidence/RIPEAE6C99CEB4A528D11 |
rdf:type |
ripe:StudyDesignEvidenceStudy design evidence |
ripekg:study-design-evidence/RIPEAE6C99CEB4A528D11 |
rdf:type |
tido:Evidence |
ripekg:study-design-evidence/RIPEAE6C99CEB4A528D11 |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEAE6C99CEB4A528D11 |
ripekg:study-design-evidence/RIPEAE6C99CEB4A528D11 |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEAE6C99CEB4A528D11 |
ripekg:study-design-evidence/RIPEAE6C99CEB4A528D11 |
ripe:concerns |
ripekg:work/10.1159%2F000438465Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial |
ripekg:study-design-evidence/RIPEAE6C99CEB4A528D11 |
ripe:recruitmentEndDateExtractionRationale |
No explicit recruitment end date found. |
ripekg:study-design-evidence/RIPEAE6C99CEB4A528D11 |
ripe:recruitmentStartDate |
02-2015 |
ripekg:study-design-evidence/RIPEAE6C99CEB4A528D11 |
ripe:recruitmentStartDateExtractionRationale |
Methods: 'The current randomized double-blind, placebo-controlled, clinical trial was performed from February 2015 to April 2015'; no specific day found. |
ripekg:study-design-evidence/RIPEAE6C99CEB4A528D11 |
ripe:studyEndDate |
04-2015 |
ripekg:study-design-evidence/RIPEAE6C99CEB4A528D11 |
ripe:studyEndDateExtractionRationale |
Methods: 'The current randomized double-blind, placebo-controlled, clinical trial was performed from February 2015 to April 2015'; no specific study end date found. |
ripekg:study-design-evidence/RIPEAE6C99CEB4A528D11 |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEAE6C99CEB4A528D11-human-2-2 |
ripekg:study-design-evidence/RIPEAE6C99CEB4A528D11 |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEAE6C99CEB4A528D11-inspectai-2-2 |